Meril, a Gujarat-based medical devices company, launched an indigenously developed surgical robotic technology, MISSO, which will provide assistance to doctors has during knee replacement surgeries in real-time.
It is expected to make these surgeries up to 66 per cent cheaper.
Banking on affordability, Meril aims to sell around 100 such robotic systems in the aiming to first year, and in around 16 three years, it plans to sell around 1,000 such units.
The company claimed that at 2 crore, MISSO is priced around 66 per cent lesser than the available robotic knee replacement systems in the Indian market.
この記事は Business Standard の June 21, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Business Standard の June 21, 2024 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Technology changes BFSI sector
Firms in the industry are undergoing a major digital transformation, with technologies - Cloud, Al, GenAI, RPA, and blockchain - leading the way, says a Business Standard-Everest Group report
Making sense of India's real estate boom
Growth drivers in real estate include urbanisation, disposable incomes, and demand for residential, commercial, and logistics spaces, according to a Business Standard-Knight Frank report
THE BIGGEST BFSI SUMMIT IS EVEN BIGGER NOW
The largest financial sector event in the country - the Business Standard BFSI Insight Summit - is back this year in a bigger form.
Shares of Adani Ports anchor at 5-month low
Down 5% in two days after business update for October
Markets rebound as investors cast wide net for value
In-demand financial stocks drive the rally
Global mkt: Stocks, Treasury yields gain as US votes
World stocks rose and Treasury yields rebounded on Tuesday while an index of market volatility retreated, as markets awaited early indications of the outcome of a knife-edge US election, with only currency markets showing some jitters.
Upper-teens EPS growth likely for Gland Pharma in next two financial yrs
Gland Pharma's Q2FY25 results beat muted expectations, with upper-teens EPS growth projected over the next two financial years despite a slowdown in US sales and temporary issues at its Cenexi subsidiary.
Sagility India IPO booked 22% on Day 1
The initial public offering (IPO) of Sagility India Ltd, a technology-enabled services provider in the health care space, received 22 per cent subscription on the first day of bidding on Tuesday.
Record FPI exodus throws a shadow on stock markets
Foreign investors are souring on India's stock market, selling a record amount of shares amid signs the South Asian nation's post-pandemic economic boom is losing steam.
Govt may divest 2.5% in HZL through OFS
The Centre is planning to sell 2.5 per cent of the total share capital of Hindustan Zinc Ltd (HZL) through an offer for sale (OFS) on Wednesday and Thursday for ₹505 per share.
